BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

82 related articles for article (PubMed ID: 11728972)

  • 1. Mechanisms activated by kidney disease and the loss of muscle mass.
    Mitch WE; Price SR
    Am J Kidney Dis; 2001 Dec; 38(6):1337-42. PubMed ID: 11728972
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mechanisms activating proteolysis to cause muscle atrophy in catabolic conditions.
    Mitch WE; Price SR
    J Ren Nutr; 2003 Apr; 13(2):149-52. PubMed ID: 12671840
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Cellular mechanisms controlling protein degradation in catabolic states.
    Ding X; Price SR; Bailey JL; Mitch WE
    Miner Electrolyte Metab; 1997; 23(3-6):194-7. PubMed ID: 9387115
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Proteolysis, the ubiquitin-proteasome system, and renal diseases.
    Debigaré R; Price SR
    Am J Physiol Renal Physiol; 2003 Jul; 285(1):F1-8. PubMed ID: 12788783
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Metabolic acidosis stimulates protein metabolism in uremia.
    Mitch WE
    Miner Electrolyte Metab; 1996; 22(1-3):62-5. PubMed ID: 8676827
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Cellular mechanisms causing loss of muscle mass in kidney disease.
    Mitch WE; Du J
    Semin Nephrol; 2004 Sep; 24(5):484-7. PubMed ID: 15490416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Sensitivity and protein turnover response to glucocorticoids are different in skeletal muscle from adult and old rats. Lack of regulation of the ubiquitin-proteasome proteolytic pathway in aging.
    Dardevet D; Sornet C; Taillandier D; Savary I; Attaix D; Grizard J
    J Clin Invest; 1995 Nov; 96(5):2113-9. PubMed ID: 7593595
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [The ubiquitin-proteasome system: the relationship between protein degradation and human diseases].
    Amir R; Ciechanover A; Cohen S
    Harefuah; 2001 Dec; 140(12):1172-6, 1229. PubMed ID: 11789303
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Chemotherapy inhibits skeletal muscle ubiquitin-proteasome-dependent proteolysis.
    Tilignac T; Temparis S; Combaret L; Taillandier D; Pouch MN; Cervek M; Cardenas DM; Le Bricon T; Debiton E; Samuels SE; Madelmont JC; Attaix D
    Cancer Res; 2002 May; 62(10):2771-7. PubMed ID: 12019153
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mechanisms accelerating muscle atrophy in catabolic diseases.
    Mitch WE
    Trans Am Clin Climatol Assoc; 2000; 111():258-69; discussion 269-70. PubMed ID: 10881345
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Insights into the abnormalities of chronic renal disease attributed to malnutrition.
    Mitch WE
    J Am Soc Nephrol; 2002 Jan; 13 Suppl 1():S22-7. PubMed ID: 11792758
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Robert H Herman Memorial Award in Clinical Nutrition Lecture, 1997. Mechanisms causing loss of lean body mass in kidney disease.
    Mitch WE
    Am J Clin Nutr; 1998 Mar; 67(3):359-66. PubMed ID: 9497177
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Necessary but not sufficient: the role of glucocorticoids in the acidosis-induced increase in levels of mRNAs encoding proteins of the ATP-dependent proteolytic pathway in rat muscle.
    Price SR; Bailey JL; England BK
    Miner Electrolyte Metab; 1996; 22(1-3):72-5. PubMed ID: 8676830
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Proteolytic mechanisms, not malnutrition, cause loss of muscle mass in kidney failure.
    Mitch WE
    J Ren Nutr; 2006 Jul; 16(3):208-11. PubMed ID: 16825021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Cellular signals activating muscle proteolysis in chronic kidney disease: a two-stage process.
    Du J; Hu Z; Mitch WE
    Int J Biochem Cell Biol; 2005 Oct; 37(10):2147-55. PubMed ID: 15982920
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Protein degradation and apoptotic death in lymphocytes during Fiv infection: activation of the ubiquitin-proteasome proteolytic system.
    Piedimonte G; Crinelli R; Della Salda L; Corsi D; Pennisi MG; Kramer L; Casabianca A; Sarli G; Bendinelli M; Marcato PS; Magnani M
    Exp Cell Res; 1999 May; 248(2):381-90. PubMed ID: 10222130
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nutrition in CAPD: serum bicarbonate and the ubiquitin-proteasome system in muscle.
    Pickering WP; Price SR; Bircher G; Marinovic AC; Mitch WE; Walls J
    Kidney Int; 2002 Apr; 61(4):1286-92. PubMed ID: 11918735
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Kidney growth during catabolic illness: what it does not destroy makes it grow stronger.
    Franch HA
    J Ren Nutr; 2007 May; 17(3):167-72. PubMed ID: 17462548
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The ubiquitin-proteasome proteolytic pathway: destruction for the sake of construction.
    Glickman MH; Ciechanover A
    Physiol Rev; 2002 Apr; 82(2):373-428. PubMed ID: 11917093
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diverse roles for ubiquitin-dependent proteolysis in transcriptional activation.
    Lipford JR; Deshaies RJ
    Nat Cell Biol; 2003 Oct; 5(10):845-50. PubMed ID: 14523392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.